Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and 10-week resistance band exercises for obese individuals of Multan
IRCT20230202057310N15Phase 2Completed
- Sponsor
- Muhammad Institute of Medical and Allied Sciences
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rosuvastatin in obesity, sponsored by Muhammad Institute of Medical and Allied Sciences. Started Jan 2025; status: completed.
02
Drugs
rosuvastatin
03
Conditions
obesity
Beyond the preview
Go deeper on IRCT20230202057310N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230202057310N15.